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ABSTRACT
Objective To evaluate the cost effectiveness, cost utility,
and cost-benefit of an integrated care programme
compared with usual care for sick listed patients with
chronic low back pain.
Design Economic evaluation alongside a randomised
controlled trial with 12 months’ follow-up.
Setting Primary care (10 physiotherapy practices, one
occupational health service, one occupational therapy
practice) and secondary care (five hospitals) in the
Netherlands, 2005-9.
Participants134adultsaged18-65sicklistedbecauseof
chronic low back pain: 66 were randomised to integrated
care and 68 to usual care.
Interventions Integrated care consisted of a workplace
intervention based on participatory ergonomics, with
involvement of a supervisor, and a graded activity
programme based on cognitive behavioural principles.
Usual care was provided by general practitioners and
occupational physicians according to Dutch guidelines.
Main outcome measures The primary outcome was
duration until sustainable return to work. The secondary
outcome was quality adjusted life years (QALYs),
measured using EuroQol.
Results Total costs in the integrated care group (£13165,
SD £13600) were significantly lower than in the usual
care group (£18475, SD £13616). Cost effectiveness
planes and acceptability curves showed that integrated
care was cost effective compared with usual care for
return to work and QALYs gained. The cost-benefit
analysesshowedthatevery£1investedinintegratedcare
wouldreturnanestimated£26.Thenetsocietalbenefitof
integrated care compared with usual care was £5744.
Conclusions Implementation of an integrated care
programme for patients sick listed with chronic low back
pain has a large potential to significantly reduce societal
costs, increase effectiveness of care, improve quality of
life, and improve function on a broad scale. Integrated
care therefore has large gains for patients and society as
well as for employers.
INTRODUCTION
Low back pain is one of the most common health
problems in industrialised countries.
1 Despite its
favourable course, low back pain is commonly asso-
ciated with high costs to society: the annual costs as a
result of low back pain were estimated to be £12bn
(€14bn; $19bn) in the United Kingdom in 1998
2 and
$5bn in the Netherlands in 1991.
3 The economic bur-
den of low back pain is primarily related to costs of
lossesin productivity (93%).Thecosts ofdirecthealth-
care are much lower (7%).
3 About 10% to 25% of
patients with persistent chronic low back pain incur
most of the costs (75%).
4-6
A need exists to develop cost effective interventions
forpatientswithchroniclowbackpain.Arecentreview
on economic analyses of interventions to manage dis-
ability concluded that only few intervention studies
undertook economic analyses and for those that did
the quality was generally low. Most economic analyses
were done from workplace and insurer perspectives.
7
We carried out an economic evaluation from a soci-
etalperspectiveofanintegratedcareprogrammecom-
pared with usual care forpatients sicklisted because of
chronic low back pain. The results of the effectiveness
evaluationofintegratedcarehaveshownthatsuchcare
is effective for return to work and functional status.
8
We report on the cost effectiveness, cost utility, and
cost-benefit of integrated care compared with usual
care. These results will be meaningful for both clini-
cians and planners of health policy.
METHODS
We carried out an economic evaluation alongside a
randomised controlled trial comparing integrated
care with usual care for patients on sick leave because
of chronic low back pain. The study was done in the
Netherlands between November 2005 and February
2009. The follow-up period was 12 months. Patients
gave written informed consent. Details of the study
design are discussed elsewhere.
9
Study population
Patientswhovisitedanoutpatientclinicofthefivepar-
ticipating hospitals because of low back pain were
approached. Eligible participants were adults aged
18-65 who had low back pain lasting more than
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employed) for at least eight hours a week, and were
on (partial) sick leave. We excluded people who had
been absent from work for more than two years;
worked temporarily for an employment agency with-
out detachment; had specific low back pain due to
infection, tumour, osteoporosis, rheumatoid arthritis,
fracture, or inflammatory process; had undergone
lumbar spine surgery in the past six weeks or had to
undergo surgery or invasive examinations in the next
three months; had a serious psychiatric or cardio-
vascular illness; were pregnant; or were dealing with
a lawsuit against their employer.
Randomisation and blinding
Randomisation was done at patient level. An indepen-
dent statistician prepared the computer generated ran-
domisationscheme.Patientswereprestratifiedbytype
of work (physically or mentally demanding) and by
durationofsickleave(moreorlessthanthreemonths).
After completing a baseline questionnaire and giving
informedconsent,patientswererandomlyallocatedto
either integrated care or usual care.
Patients, healthcare professionals, and researchers
were not blinded for group assignment. All patients
receivedacodeaccordingtowhicharesearchassistant
entered all data in the computer. This ensured blinded
analysis of the data by the researcher.
Interventions
Patients allocated to usual care were referred to their
occupational physician and general practitioner with a
letter containing the advice to treat them according to
the Dutch guidelines for patients with low back
pain.
1011Theseguidelinesare evidence basedand pro-
viderecommendationsforthemanagementofpatients
with low back pain.
Patients allocated to integratedcare were referred to
a clinical occupational physician who was responsible
forthecoordinationofthecareandforcommunication
with the other healthcare professionals in the team.
Theinterventionconsistedofaworkplaceintervention
protocol and a graded activity protocol. The work-
place intervention protocol, based on participatory
ergonomics, was a stepwise process involving the par-
ticipant and supervisor and aimed to formulate a con-
sensus based plan for adaptations at work to facilitate
return to work.
12-14 Graded activity was a time contin-
gent programme based on cognitive behavioural
principles.
15-17 The integrated care team consisted of a
medical specialist, occupational therapist, physio-
therapist,and clinical occupational physician.The pri-
mary aim of integrated care was to restore
occupational functioning and to achieve lasting return
to work for patients in their own job or similar work.
Main outcome measures
The primary outcome was duration until sustainable
return to work. This was defined as sick leave due to
low back pain in calendar days from randomisation
until full return to work in own or other work with
equal earnings, for at least four weeks without partial
or full drop-out. The secondary outcome was quality
adjusted life years (QALYs) measured using the Euro-
Qol. We used the Dutch tariff to estimate the utility of
health states described by the patients.
18 QALYs were
calculatedbymultiplyingtheutilitywiththeamountof
timeapatientspentinaparticularhealthstateandthen
linearly interpolating the transitions between the four
measured health states.
19
Resource use and valuation
Data were collected from a societal perspective during
12months.Questionnairesmeasuringuseofresources
with a three month recall period were posted to the
patients at 3, 6, 9, and 12 months after randomisation.
Ifquestionnaireswerenotreturned,wecollectedinfor-
mation by telephone. Questionnaires included direct
healthcarecostsanddirectnon-healthcarecosts.Direct
healthcare costs comprised visits for primary and sec-
ondary care, home care, and drugs. Direct non-health-
care costs included visits to a therapist in alternative
medicine and informal help. We used standard costs
for the Netherlands.
20 The prices of prescribed drugs
of the Royal Dutch Society for Pharmacy were used.
21
Costs of the integrated care programme were calcu-
lated using the bottom-up approach (see web extra).
The index year for this study was 2007. We used the
purchasing power parities for gross domestic product
of 2007 (0.732 049 216) to exchange euros into UK
sterling. Discounting of costs was not necessary
because the follow-up was one year.
22
Allocated to usual care (n=68) Allocated to integrated care (n=66)
Received total treatment (n=61)
(1 withdrew; 1 no job; 1 recovered; 1 quit job;
1 no approval from employer)
Eligible participants (n=219)
Randomised (n=134)
Available data during follow-up
Healthcare consumption, utility (n=59)
Sick leave data (n=61)
Available data during follow-up
Healthcare consumption, utility (n=58)
Sick leave data (n=63)
Intention to treat (n=68)
Complete dataset (n=59, 82%)
(4 withdrew; 1 unreachable; 2 lost interest;
1 questionnaire lost in post; 1 died)
Intention to treat (n=66)
Complete dataset (n=58, 88%)
(1 withdrew; 2 questionnaire lost in post;
2 recovered; 1 dissatisfied about treatment;
1 no job; 1 lost interest)
Excluded (n=85):
  Specific low back pain (n=5)
 Surgery (n=20)
 Temporary job (n=10)
 Disability pension (n=5)
 Psychiatric condition (n=5)
 Cardiovascular disease (n=5)
 Pregnant (n=3)
 Lawsuit (n=3)
 Insufficient command of Dutch language (n=14)
 No informed consent (n=15)
Fig 1 | Flow of participants in study
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Patients recorded absenteeism from work retrospec-
tively using monthly calendars, and after 12 months
the database of the occupational health services. If
calendars were not returned, we collected information
by telephone. We used the human capital approach to
calculate the costs of losses to production as a result of
sick leave due to low back pain, by multiplying the net
number of days on sick leave during follow-up by the
estimated price of production loss of a worker per day
ofsickleavebasedonageandsex.Incaseofpartialsick
leave, we assumed that participants were 100% pro-
ductive during the hours of partial work resumption.
We converted the cumulative net number of days of
sick leave into work hour equivalents based on a
Dutch average of 1540 work hours per year.
23
Statistical analysis
The economic evaluation was done according to the
intention to treat principle. The sample size of the
study(n=130) was based ondetecting a relevant differ-
ence on return to work (hazard ratio of 2.0) with a
powerof80%andasignificancelevelof5%.
24Formiss-
ingdataonfollow-upweusedthemultivariateimputa-
tion by chainedequations to complete missingdata on
costs.
25ThismethodwascarriedoutusingSPSS17.0in
which an imputation model containing important
demographicandprognosticvariableswasusedtocre-
ate five complete datasets. SPSS 17.0 uses Rubin’s
rules to pool effects and costs from the five complete
datasets.
26Forthecosteffectivenessanalyses,wecalcu-
latedtheincrementalcosteffectivenessratiosbydivid-
ing the incremental costs by the incremental effects.
The incremental cost effectiveness ratio indicates the
additional investments needed for the intervention to
gain one extra unit of effect compared with usual care.
To avoid double counting we excluded productivity
costsduetosickleaveintheincrementalcosteffective-
ness ratio with sick leave as effect measure. The incre-
mental cost utility ratio was calculated by the
incremental costs (direct costs plus costs of productiv-
ity losses) divided by the difference in QALYs. In the
cost-benefit analysis,the net societal benefit wascalcu-
latedbysubtractingthedifferenceindirectcosts(costs)
between the two groups from the difference in indirect
costs(benefits)betweenthegroups.Areturnoninvest-
ment was calculated by dividing the benefit of an
investment (gain minus cost) by the cost of the
investment.
27 We used bootstrapping with 5000 repli-
cations to estimate the uncertainty surrounding the
cost differences and the incremental cost effectiveness
ratio and incremental cost utility ratio. The approxi-
mate bootstrap confidence algorithm was used to esti-
mate the 95% confidence intervals around the mean
cost differences.
28 Bootstrapped cost effect pairs were
used to estimate cost effectiveness planes and cost
effectiveness acceptability curves. Such curves show
the probability that a treatment is cost effective at a
specific ceiling ratio, which is the amount of money
society is willing to pay to gain one extra unit of effect.
To assessthe robustnessofthe resultswe carriedout
six sensitivity analyses. Firstly, we did a complete case
analysis to assess the cost effectiveness of the inter-
ventions without the missing data from 17 patients
who were lost to follow-up. Secondly, we did a cost
effectiveness analysis according to the per protocol
principle. We excluded patients in the integrated care
group who did not receive all components of the inte-
grated care programme (n=5). Thirdly, we did a cost
effectiveness analysis without patients over 55 years of
age to see if these patients use the claim of low back
pain as an alternative to retirement. Fourthly, we car-
ried out a sensitivity analysis in which the intervention
costsweredoubled.Fifthly,wecarriedoutasensitivity
analysis to test our assumption in the main analyses
that participants were 100% productive during the
hours of partial work resumption. Finally, we varied
the productivity of patients between 50% or 80% dur-
ing these hours of partial return to work. Data proces-
singandmultipleimputationsweredoneinSPSS17.0.
Bootstrapping was carried out in R (R Foundation for
Statistical Computing).
RESULTS
BetweenNovember2005andApril2007,219patients
were eligible for participation (fig 1). Of those, 134
signed informed consent and were randomised to
Table 1 |Baseline characteristics and prognostic factors of outcome measures. Values are
numbers (percentages) unless stated otherwise
Variables Integrated care (n=66) Usual care (n=68)
Baseline characteristics
M e n 3 7( 5 6 ) 4 1( 6 0 )
Women 29 (44) 27 (40)
Mean (SD) age (years) 45.5 (8.9) 46.8 (9.2)
Level of education*:
L o w 1 4( 2 1 ) 2 3( 3 4 )
Intermediate 34 (52) 32 (47)
High 18 (27) 13 (19)
Mean (SD) job content questionnaire†:
Job control 74.3 (10.3) 72.5 (10.5)
Job demands 33.2 (4.7) 33.0 (4.4)
Social support 23.5 (4.2) 23.3 (3.6)
Kind of work:
Physically demanding 42 (64) 42 (62)
Mentally demanding 24 (36) 26 (38)
Partial absence from work 34 (52) 36 (53)
Full absence from work 32 (48) 32 (47)
Mean (SD) expectation of patient about return to work
at baseline (score 1-5)‡
2.9 (1.3) 2.3 (1.2)
Prognostic factors
Median (interquartile range) days off work before
inclusion
142 (54-173) 163 (64-240)
Mean (SD) functional status (score 0-23)§ 14.7 (5.0) 15.0 (3.6)
Mean (SD) pain intensity (score 0-10)¶ 5.7 (2.2) 6.3 (2.1)
*Low=preschool, primary school; intermediate=lower and upper secondary; high=tertiary education, university,
or postgraduate.
†Higher score means a higher level of job control (score 40-94), job demands (score 22-44), social support
(score 10-32).
‡Scores can range from 1 to 5. Higher scores indicate more confidence to return to work.
§Scores can range from 0 to 23. Higher scores indicate greater reductions in daily activities.
¶Scores can range from 0 to 10. Higher scores indicate more pain.
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pants’ demographic and prognostic variables did not
differsignificantlybetweengroups(table1).Seventeen
participantswerelosttofollow-up.Reasonswerewith-
drawal(n=5),lossofinterest(n=3),questionnairelostin
post (n=3), recovered (n=2), unreachable (n=1), no job
(n=1),dissatisfiedabouttreatment(n=1),and dieddur-
ing follow-up (n=1). About 13% of data on healthcare
utilisation and EuroQol and 8% on sick leave were
missing.Baselinecharacteristicsdidnotdifferbetween
patients with and without complete follow-up.
Healthcare utilisation
Participantswhoreceivedusualcareconsultedthegen-
eral practitioner, physiotherapist, exercise therapist,
manual therapist, and psychologist more often than
participants who received integrated care, and they
usedmoreinformalcareandhadlongerstaysinhospi-
tal (table 2). In both groups, visits to healthcare provi-
ders were mainly restricted to a physiotherapist and
manual therapist. Modifications at work had been
applied for 29 of 66 patients in the integrated care
group and 20 of 68 in the usual care group.
Costs
Losses to productivity were the greatest contributor to
total costs in both groups (89% in the integrated care,
93% in usual care; table 3). Total costs and indirect
costs were significantly lower in the integrated care
group. Primary care costs were significantly higher in
the integrated care group, as a result of the costs asso-
ciated with integrated care (cost £1077). Despite this,
total direct costs did not differ significantly between
groups.
Cost effectiveness analyses
The main analysis (table 4) showed that the incremen-
tal cost effectiveness ratio for sustainable return to
work was −3 (mean difference in healthcare costs
(£217) divided by the mean difference in net sick
leave (−68 days) for the total group). An additional £3
would therefore need to be invested in integrated care
foronedayearlierreturntoworkcomparedwithusual
care. Figure 2 shows the cost effectiveness plane for
sustainable return to work. Overall, 86% of the boot-
strapcosteffectpairsarelocatedinthenortheastquad-
rant, which confirms that integrated care was more
effective and associated with higher costs than usual
care. The figure indicates that for a willingness to pay
£10 for one day earlier return to work the probability
that the integrated care is cost effective was 95%.
Cost utility analyses
The difference in QALYs gained over 12 months
between the two groups was small but significant
(0.09 on a scale of 0 to 1), and the cost difference was
−£5310, resulting in a negative large incremental cost
utility ratio of −£61000. Table 4 shows that 98% of the
bootstrapped cost utility pairs were situated in the
southeast quadrant, representing more effectiveness
and fewer costs for integrated care than for usual
care. According to this analysis, integrated care is
dominanttousualcare,meaningthatitiscosteffective
compared with usual care regardless of the willingness
to pay per QALY.
Cost-benefit analyses
The cost-benefit analyses from a societal perspective
showed that the mean difference in direct costs was
£217 (95% confidence interval −£131 to £662) in
favour of the usual care group. The benefit (difference
in productivity costs) was −£5527 (−£10160 to −£740)
per patient in favour of the integrated care group. The
returnon investmentfroma societalperspectivewas −
£26 (−£5527 minus £217 divided by £217)—that is,
every £1 invested in integrated care will return an esti-
mated £26. The net societal benefit of the integrated
care compared with usual care was £5744 (£217
minus −£5527).
Sensitivity analyses
Results of the complete case analysis were similar to
the multiple imputation analysis,althoughthe cost dif-
ference between the two groups was no longer
Table 2 |Costs of resource use and utilisation in groups receiving integrated care or usual
care for chronic low back pain. Values are means (standard deviations) unless stated
otherwise
Type of utilisation
Cost price
(£)*
Integrated care
(n=58)
Usual care
(n=59)
Primary care:
General practitioner (No of visits) 16† 0.4 (1.1) 0.6 (1.9)
Physiotherapist (No of visits) 18† 7.7 (14.6) 21.7 (28.5)
Occupational physician (No of visits) 162† 0.8 (3.3) 0.6 (1.4)
Mensendieck therapy (No of visits) 18† 0.3 (2.0) 2.3 (11.9)
Manual therapy (No of visits) 249† 1.2 (4.9) 5.4 (13.6)
Psychologist (No of visits) 59† 0.2 (1.4) 0.9 (4.6)
Integrated care 1077‡ 0
Clinical occupational physician 2.2 (1.1)
Physiotherapist 14.8 (9.6)
Occupational therapist 2.4 (0.3)
Other physiotherapy§ (No of visits) Range 3-105 0.2 (1.6) 0.1 (0.5)
Multidisciplinary case¶ management Range 2928-3204 0.0 (0.1) 0.2 (1.7)
Insurance physician (No of visits) 109† 0 0.0 (0.24)
Secondary care:
Diagnostic tests** (No of tests) Range 17-938†,†† 2.8 (7.3) 4.7 (8.1)
Hospital stay (No of days) Range 261-369† 0.0 (0.2) 1.7 (0.9)
Medical specialist (No of visits) 53† 0.8 (3.3) 0.6 (1.4)
Alternative therapy‡‡ (No of visits) Range 18-60** 2.2 (6.5) 2.8 (9.1)
Informal care costs 6† 3.6 (11.4) 9.6 (18.0)
Productivity losses
Absenteeism from work (No of net days) Production loss per hour
based on age and sex†
88.5 (95.5) 130.4 (102.7)
*Conversion from euros into UK sterling (£) using purchasing power parities for gross domestic product of 2007
(0.732 049 216).
†Price according to Dutch guidelines for costing studies.
‡Determined by bottom-up calculation.
§Consisting of four kinds of physiotherapy.
¶Consisting of two kinds of case management.
**11 different diagnostic tests used on patients.
††Price according to professional organisation or healthcare providers.
‡‡Patients consulted 14 different alternative healthcare providers.
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second sensitivity analysis, a per protocol analysis,
were similar to the main analysis. Results of the sensi-
tivity analyses in which patients over 55 were
excluded, the costs for the integrated care programme
doubled, and varying the productivity between 50%
and 80% during partial return to work did not differ
from the main analysis (table 4).
DISCUSSION
An integrated care programme for patients sick listed
because of chronic low back pain had substantial eco-
nomic benefits over usual care. Indirect costs and total
societal costs related to low back pain and sustainable
return to work and QALYs gained were significantly
more favourable in the integrated care group than
usual care over a 12 month follow-up period. Cost
effectiveness acceptability curves indicated that the
probabilityofintegratedcarebeingcosteffectivecom-
pared with usual care was larger than 95% for ceiling
ratios larger than £10 for sustainable return to work.
ForQALYsgained,thecosteffectivenessacceptability
curves indicated that integrated care was cost effective
for all possible ceiling ratios.
Strengths and limitations of the study
The main strengths of the study were the measures
taken to prevent bias, the minimal loss to follow-up,
and the use of a societal perspective for the economic
evaluation. Firstly, the primary outcome was assessed
accurately by collecting sick leave data every month
from patients and by checking these data with the
sick leave data of registration systems of the occupa-
tional health services. Assessing sick leave every
month assured that recall bias was small. Secondly,
only 10 patients were lost to follow-up; only five of
the 66 patients did not participate in the intervention
programme, and only 15% of data were missing.
Another strength of the study was the execution of
the cost effectiveness evaluation from a societal
perspective. This perspective has two advantages: the
results of this economic evaluation can be used for
resource allocation at Dutch societal level but can
also be translated to another context, and data can
also be disaggregated and analysis can be done from
a different perspective.
29
Limitations to the methodology may have influ-
enced the results of this study. As the cost of the work
modifications was not registered, we may have under-
estimated the cost of the integrated care. However, we
do not think the results would have changed for two
reasons: firstly, adaptations to the workplace were
also carried out in the usual care group (n=20), and
secondly, the conclusion in a review about job accom-
modations for employees with low back pain was that
inatleastaquarterofthecases,workadaptationscould
bedoneforlessthan$500.
30Secondly,theuseofretro-
spective questionnaires may have reduced the reliabil-
ity of the data. It might have been better to collect data
on costs prospectively, although recall information for
three months has been shown to be valid.
31
Comparison with other studies
To date, cost effectiveness studies investigating com-
parable interventions for patients sick listed because
of chronic low back pain are not available. Some eco-
nomic evaluations have evaluated comparable inter-
ventions for sick listed employees with subacute or
acute low back pain.
32-34 These studies had conflicting
results. One study showed that a similar combination
of a workplace intervention and multidisciplinary
work rehabilitation was cost beneficial and cost effec-
tive at a mean follow-up of 6.4 years. Contrary to this
Table 3 |Pooled mean total effects and costs and differences in mean total effects and costs
during follow-up
Pooled variables
Mean total effect (SD)
Mean difference
(95% CI)
Integrated care
(n=66)
Usual care
(n=68)
Effects
Mean (SD) total effect:
Days until sustainable return to work 129 (117) 197 (129) −68 (−110 to −26)
QALY 0.74 (0.19) 0.65 (0.21) 0.09 (0.01 to 0.16)
Costs
Mean (SD) total costs (£):
Total direct costs* 1479 (1133) 1262 (1094) 217 (−131 to 662)
Primary care costs 1251 (700) 857 (758) 395 (131 to 687)
Secondary care costs 124 (416) 247 (425) −122 (−274 to 43)
Direct non-healthcare costs 104 (225) 159 (325) −55 (−196 to 98)
Total indirect costs 11 686 (12 553) 17 213 (13 416) −5527 (−10 160 to −740)
Total costs† 13 165 (13 600) 18 475 (13 616) −5310 (−10 042 to −391)
*Direct healthcare costs added to direct non-healthcare costs.
†Total direct costs added to indirect costs.
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not show that the combination of workplace inter-
vention and graded activity was cost effective com-
pared with usual care after a one year follow-up.
3435
Policy implications and recommendations
Limited healthcare budgets are making economic eva-
luations increasingly important. This study with
12 months’ follow-up shows the implementation of
the integrated care programme for patients sick listed
because of chronic low back pain to be promising on a
broad scale. The effects of the integrated care
programmeafter12monthsareunknown.Studiestest-
ingthelongtermeffectsofcomparableinterventionsin
patients sick listed for subacute or acute low back pain
showed that their intervention was cost beneficial and
cost effective after one year.
3637 Therefore we expect
that the effect of integrated care in the long term will
be even larger for society, patients, and employers.
Research is needed to confirm this hypothesis.
Conclusions
The costs of an integrated care programme for patients
sick listed because ofchronic low back pain werelower
than for usual care. From a societal perspective after
12 months integrated care was more cost effective than
usual care. This applied to a selected group of patients
with chronic specific and (non-)specific low back pain,
all of whom were judged appropriate for this kind of
psychosocial treatment. The integrated care pro-
gramme has large potential to significantly reduce soci-
etal costs and improve quality of life and function. The
successandfailuresofimplementingtheintegratedcare
programme need to be investigated to determine the
boundary conditions for nationwide application.
Contributors: LCL and JRA were responsible for the general coordination
of the study and implemented the integrated care programme. LCL
collected the data. WvM is guarantor. All authors designed the study,
helped to write the manuscript, and read and approved the final version
of the manuscript.
Funding:ThisstudywassupportedbyVUUniversityMedicalCenter,TNO
Work and Employment, Dutch Health Insurance Executive Council,
Table 4 |Results of cost effectiveness and cost utility analyses
Outcome effect
Sample size
Cost difference (£)
(95% CI)
Effect difference
(95% CI)
ICER/
ICUR
Distribution (%) cost effectiveness plane
(quadrant)
Integrated
care group
Usual care
group
North
east*
South
east†
South
west‡
North
west§
Main analysis:
Return to work 66 68 217 (−131 to 662) −68 (−110 to −26) −38 61 4 0 0
QALY 66 68 −5310 (−10 042 to −391) 0.09 (0.01 to 0.16) −61 000 2 98 1 0
>55 years:
Return to work 57 60 100 (−265 to 602) −47 (−92 to −2) −26 63 3 0 2
QALY 57 60 −3744 (−18 683 to 1524) 0.09 (0.01 to 0.17) −42 000 8 91 1 0
Per protocol:
Return to work 61 68 230 (−114 to 698) −67 (−110 to −23) −38 81 2 0 0
QALY 61 68 −5180 (−10 019 to −72) 0.09 (0.02 to 0.16) −57 000 2 97 1 0
Complete cases:
Return to work 58 59 142 (−217 to 630) −72 (−117 to −26) −27 52 5 0 0
QALY 58 59 −4481 (−9058 to 259) 0.09 (0.02 to 0.17) −48 000 3 96 0 0
Double intervention costs:
Return to work 66 68 999 (627 to 1461) −68 (−110 to −26) −15 100 0 0 0
QALY 66 68 −4528 (−9264 to 390) 0.09 (0.01 to 0.16) −52 000 3 96 1 0
50% productivityonpartialreturn
to work:
QALY 66 68 −6497(−11341to−1397) 0.09 (0.01 to 0.16) −66 000 1 99 0 0
80% productivityonpartialreturn
to work:
QALY 66 68 −4529 (−9176 to 241) 0.09 (0.01 to 0.16) −46 000 3 97 0 0
ICER=incremental cost effectiveness ratio. Incremental cost utility ratio (ICUR) is calculated by difference in costs divided by difference in quality adjusted life years (QALYs).
*Integrated care more effective and more costly than usual care.
†Integrated care more effective and less costly than usual care.
‡Integrated care less effective and less costly than usual care.
§Integrated care is less effective and more costly than usual care.
WHAT IS ALREADY KNOWN ON THIS TOPIC
The economic burden of low back pain is huge and primarily related to costs of productivity
losses
A small group of patients with severe, chronic low back pain generate most of the costs
Cost effective interventions are lacking for this selected group with chronic back pain
WHAT THIS STUDY ADDS
Anintegratedcareprogrammesubstantiallyreducedsickleavefor asmallbut relevantgroup
of patients with chronic low back pain
Theprogramme has large potentialto significantly reduce the societal costsof low backpain
in this group of patients
Integrated care was more cost effective than usual care for return to work and quality
adjusted life years
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